Catalyst Wire Dossier Catalyst Wire Dossier

US-licensed epoetin alfa

epoetin alfa · Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for US-licensed epoetin alfa, covering 2017-05-12 to 2017-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa [Phase 3]

See pricing